These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13631997)

  • 1. Acute hepatic necrosis following iproniazid therapy; value of glutamic-oxaloacetic transaminase estimation in early detection.
    PARE CM; SANDLER M
    Lancet; 1959 Feb; 1(7067):282-4. PubMed ID: 13631997
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive necrosis of the liver following iproniazid.
    SHAY H; SUN DC
    Ann Intern Med; 1958 Nov; 49(5):1246-52. PubMed ID: 13595485
    [No Abstract]   [Full Text] [Related]  

  • 3. The psychiatric side-effects of iproniazid.
    CRANE GE
    Am J Psychiatry; 1956 Jan; 112(7):494-501. PubMed ID: 13283130
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathological findings in jaundice associated with iproniazid therapy.
    POPPER H
    J Am Med Assoc; 1958 Dec; 168(17):2235-42. PubMed ID: 13610612
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxic effects of iproniazid in a patient with angina.
    PAPP C; BENAIM S
    Br Med J; 1958 Nov; 2(5104):1070-2. PubMed ID: 13584852
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlorpromazine and iproniazid toxic hepatitis in the same patient.
    BERNSTEIN A; SIMON F
    AMA Arch Intern Med; 1959 Jun; 103(6):954-6. PubMed ID: 13648998
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal jaundice associated with iproniazid (marsilid) therapy: report of a case.
    FRANTZ AG
    J Am Med Assoc; 1958 Jun; 167(8):987-8. PubMed ID: 13549217
    [No Abstract]   [Full Text] [Related]  

  • 8. Jaundice associated with the administration of iproniazid; report of nine cases.
    KAHN M; PEREZ V
    Am J Med; 1958 Dec; 25(6):898-916. PubMed ID: 13606142
    [No Abstract]   [Full Text] [Related]  

  • 9. Jaundice associated with administration of iproniazid; report of two cases.
    BENAIM S; DIXON MF
    Br Med J; 1958 Nov; 2(5104):1068-70. PubMed ID: 13584851
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychiatric and neurological side-effects of isoniazid and iproniazid.
    PLEASURE H
    AMA Arch Neurol Psychiatry; 1954 Sep; 72(3):313-20. PubMed ID: 13196750
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis associated with iproniazid (marsilid); report of 3 cases.
    LEVIN HG; BERK JE; PAUL LJ; BERMAN C
    Am J Dig Dis; 1959 Apr; 4(4):297-305. PubMed ID: 13637057
    [No Abstract]   [Full Text] [Related]  

  • 12. Iproniazid hepatitis: report of five cases and review of pertinent literature.
    FELIX A; SCHWARTZ E; RIFKIN H
    AMA Arch Intern Med; 1959 Jul; 104(1):72-82. PubMed ID: 13660529
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum glutamic oxaloacetic transaminase activity and serum glutamic pyruvic transaminase activity in liver diseases.
    VANIKAR VA; BHATT JT
    Indian J Med Sci; 1960 Apr; 14():344-50. PubMed ID: 13841248
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver necrosis after iproniazid therapy; report of a case.
    MORRISON JE; KALAMBOUKIS Z
    Conn Med; 1959 Jan; 23(1):25-6. PubMed ID: 13609193
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum glutamic-oxaloacetic transaminase activity as an index of centrilobular liver cell necrosis in cardiac and circulatory failure.
    BANG NU; IVERSEN K; JAGT T; TOBIASSEN G
    Acta Med Scand; 1959 Aug; 164():385-93. PubMed ID: 13796421
    [No Abstract]   [Full Text] [Related]  

  • 16. GLUTAMIC-OXALOACETIC transaminase.
    Br Med J; 1958 Mar; 1(5070):568-9. PubMed ID: 13510731
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on serum glutamic oxaloacetic transaminase (SGOT).
    KESSLER G; PHELPS A
    J Albert Einstein Med Cent (Phila); 1956 Jun; 4(3):91-4. PubMed ID: 13331676
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver damage concurrent with iproniazid administration.
    ZETZEL L; KAPLAN H
    N Engl J Med; 1958 Jun; 258(24):1209-11. PubMed ID: 13552946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Supplementary communication on the problem of liver damage during isonicotinic acid therapy].
    ORLOWSKI EH
    Klin Wochenschr; 1953 May; 31(17-18):434-5. PubMed ID: 13070509
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the colorimetric methods in the estimation of serum glutamic oxaloacetic transaminase.
    GUPTA JC; GHOSH BP; MAL SN
    Med Exp Int J Exp Med; 1960; 3():199-205. PubMed ID: 13709809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.